Giron J, Poey C, Fajadet P, Sans N, Fourcade D, Senac J P, Railhac J J, Dahan M, Berjaud J, Krempf M
Service d'Imagerie médicale J.-Baudot, CHU Toulouse Purpan.
Rev Mal Respir. 1995;12(6):593-9.
The authors report 30 cases of the percutaneous treatment of symptomatic pulmonary aspergilloma by injection of amphotericine paste in patients who were not considered to be operable. The treated aspergillomas had developed as a sequel to bacilliary infection and pulmonary fibrosis. Surgery was contraindicated in these patients on account of severe respiratory failure. The authors specify the technique for the preparation of the paste and for the type of percutaneous injection, the aim being to obtain complete filling of the cavity and creating an anaerobic environment for the aspergillus. The contribution of this technique for the non-surgical treatment of patients appears interesting but should be carried on a larger series to identify the exact indications and the interaction with other new treatments which have just appeared.
作者报告了30例对被认为无法进行手术的有症状肺曲菌球患者经皮注射两性霉素糊剂进行治疗的病例。所治疗的肺曲菌球是细菌性感染和肺纤维化的后遗症。由于严重呼吸衰竭,这些患者禁忌手术。作者详细说明了糊剂的制备技术和经皮注射类型,目的是使空洞完全填充并为曲霉菌创造厌氧环境。这项技术对患者非手术治疗的贡献似乎很有意思,但应该在更大规模的病例系列中进行,以确定确切的适应症以及与刚出现的其他新治疗方法的相互作用。